Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Busse

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Microbial Ecology|June 4, 2014
Does the aboveground herbivore assemblage influence soil bacterial community composition and richness in subalpine grasslands?Melanie Hodel, Martin Schütz, Martijn L Vandegehuchte, et al.
Paediatric Drugs|September 15, 2021
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical TrialsStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
European Child & Adolescent Psychiatry|September 28, 2021
A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorderStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
Archives of Orthopaedic and Trauma Surgery|December 10, 2015
Treatment strategies for partial chronic instability of the distal syndesmosis: an arthroscopic grading scale and operative staging conceptC Colcuc, S Fischer, S Colcuc, et al.
Brain and Behavior|February 27, 2023
Response of peer relations and social activities to treatment with viloxazine extended-release capsules (Qelbree<sup>®</sup> ): A post hoc analysis of four randomized clinical trials of children and adolescents with attention-deficit/hyperactivity disorderStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
Psychopharmacology|January 22, 2008
The effects of nicotine on ethanol-induced conditioned taste aversions in Long-Evans ratsJennifer A Rinker, Gregory D Busse, Peter G Roma, et al.
Psychiatry Research|January 8, 2021
Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trialsStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
The Journal of Clinical Psychiatry|October 13, 2020
Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy AdultsAzmi Nasser, Shamia L Faison, Tesfaye Liranso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolismD Busse, F W Busch, F Bohnenstengel, et al.
Neuropsychiatric Disease and Treatment|June 11, 2021
The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled TrialsAzmi Nasser, Joseph T Hull, Tesfaye Liranso, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Microbial Ecology|June 4, 2014
Does the aboveground herbivore assemblage influence soil bacterial community composition and richness in subalpine grasslands?Melanie Hodel, Martin Schütz, Martijn L Vandegehuchte, et al.
Paediatric Drugs|September 15, 2021
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical TrialsStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
European Child & Adolescent Psychiatry|September 28, 2021
A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorderStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
Archives of Orthopaedic and Trauma Surgery|December 10, 2015
Treatment strategies for partial chronic instability of the distal syndesmosis: an arthroscopic grading scale and operative staging conceptC Colcuc, S Fischer, S Colcuc, et al.
Brain and Behavior|February 27, 2023
Response of peer relations and social activities to treatment with viloxazine extended-release capsules (Qelbree<sup>®</sup> ): A post hoc analysis of four randomized clinical trials of children and adolescents with attention-deficit/hyperactivity disorderStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
Psychopharmacology|January 22, 2008
The effects of nicotine on ethanol-induced conditioned taste aversions in Long-Evans ratsJennifer A Rinker, Gregory D Busse, Peter G Roma, et al.
Psychiatry Research|January 8, 2021
Early response to SPN-812 (viloxazine extended-release) can predict efficacy outcome in pediatric subjects with ADHD: a machine learning post-hoc analysis of four randomized clinical trialsStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.
The Journal of Clinical Psychiatry|October 13, 2020
Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy AdultsAzmi Nasser, Shamia L Faison, Tesfaye Liranso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolismD Busse, F W Busch, F Bohnenstengel, et al.
Neuropsychiatric Disease and Treatment|June 11, 2021
The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled TrialsAzmi Nasser, Joseph T Hull, Tesfaye Liranso, et al.
Pageof 7